Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph early_phase_1
1
25%
Ph phase_1
1
25%
Ph phase_2
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (33.3%)
Phase 11 (33.3%)
Phase 21 (33.3%)

Trials by Status

active_not_recruiting125%
completed250%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruiting

Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation

NCT03625349
completedphase_1

Plasma Triglyceride Extraction by The Muscle

NCT01860911
terminatedearly_phase_1

Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?

NCT00708357
completedphase_2

Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions

NCT00431392

Clinical Trials (4)

Showing 4 of 4 trials
NCT03625349

Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation

Active Not Recruiting
NCT01860911Phase 1

Plasma Triglyceride Extraction by The Muscle

Completed
NCT00708357Early Phase 1

Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?

Terminated
NCT00431392Phase 2

Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4